• Increasing SHMN's market share in key markets, including an extension of its leadership position in the world's emerging generic pharmaceutical markets in Africa, Latin America, and Southeast Asia and other important international markets;
  
  
• Rapidly responding to customers' most significant needs by – among others—broadening SHMN's product portfolio and executing an increasing number of launches, optimizing a truly global supply chain, helping customers more efficiently manage their inventory and customizing shipping methods based on specific customer needs;
  

Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc., stated, "Our ability to generate record revenue growth and accelerated consumer adoption rates for our generic pharmaceutical products is a direct reflection of our sales and marketing team's dedication. We continue to demonstrate our ability to penetrate and lead in our chosen emerging markets. Most significantly, [SHMN] has grown and matured its generic drug manufacturing operations allowing for the scalability of resources and product production necessary to support a growing worldwide customer base."

You can visit the Company website at: . www.sohm.com